APA (7th ed.) Citation

Liu, W., Tian, M., Tao, C., Tang, Z., Zhou, Y., Song, S., . . . Shi, Y. (2020). Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: A propensity score matching analysis. BMC cancer, 20(1), 642-11. https://doi.org/10.1186/s12885-020-07138-z

Chicago Style (17th ed.) Citation

Liu, Wei-Ren, et al. "Adjuvant Transarterial Chemoembolization Does Not Influence Recurrence-free or Overall Survival in Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma After Curative Resection: A Propensity Score Matching Analysis." BMC Cancer 20, no. 1 (2020): 642-11. https://doi.org/10.1186/s12885-020-07138-z.

MLA (9th ed.) Citation

Liu, Wei-Ren, et al. "Adjuvant Transarterial Chemoembolization Does Not Influence Recurrence-free or Overall Survival in Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma After Curative Resection: A Propensity Score Matching Analysis." BMC Cancer, vol. 20, no. 1, 2020, pp. 642-11, https://doi.org/10.1186/s12885-020-07138-z.